Last update 23 Jan 2025

Biogen U.S. Corp.

Subsidiary Company|
Massachusetts, United States

Overview

Tags

Nervous System Diseases
Congenital Disorders
Other Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
APP(Beta amyloid A4 protein)1

Related

1
Drugs associated with Biogen U.S. Corp.
Lecanemab
Target
APP
Mechanism
APP inhibitors
Active Org.
Eisai, Inc.Eisai, Inc. [+5]
Originator Org.
BioArctic ABBioArctic AB
Active Indication
Dementia due to Alzheimer's disease (disorder) [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date06 Jan 2023
1
Clinical Trials associated with Biogen U.S. Corp.
CTR20200005
/ Active, not recruitingPhase 3
一项为期18个月的安慰剂对照、双盲、平行组研究并具有开放扩展期，以确认BAN2401在早期AD患者中的安全性和疗效
[Translation] An 18-month placebo-controlled, double-blind, parallel-group study with an open-label extension to confirm the safety and efficacy of BAN2401 in patients with early AD
100 Clinical Results associated with Biogen U.S. Corp.
Login to view more data
0 Patents (Medical) associated with Biogen U.S. Corp.
Login to view more data
100 Deals associated with Biogen U.S. Corp.
Login to view more data
100 Translational Medicine associated with Biogen U.S. Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lecanemab
 ( APP )		Mild cognitive disorder
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free